News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,103 Results
Type
Article (13643)
Company Profile (109)
Press Release (249351)
Section
Business (88226)
Career Advice (464)
Deals (15394)
Drug Delivery (64)
Drug Development (36566)
Employer Resources (49)
FDA (6290)
Job Trends (6193)
News (150433)
Policy (14025)
Tag
Academia (439)
Alliances (23198)
Alzheimer's disease (374)
Approvals (6297)
Artificial intelligence (66)
Bankruptcy (143)
Best Places to Work (4353)
Biotechnology (44)
Breast cancer (60)
Cancer (399)
Career advice (406)
Cell therapy (56)
Clinical research (30563)
Collaboration (194)
Compensation (80)
COVID-19 (748)
C-suite (58)
Data (426)
Diabetes (59)
Diagnostics (1243)
Drug pricing (59)
Earnings (31697)
Employer resources (43)
Events (37087)
Executive appointments (217)
FDA (6519)
Funding (130)
Gene therapy (62)
GLP-1 (301)
Government (1271)
Healthcare (3548)
Infectious disease (768)
Inflammatory bowel disease (49)
Interviews (58)
IPO (5865)
Job creations (2051)
Job search strategy (372)
Layoffs (168)
Legal (3415)
Lung cancer (55)
Manufacturing (110)
Medical device (1486)
Medtech (1488)
Mergers & acquisitions (9605)
Metabolic disorders (185)
Neuroscience (486)
NextGen Class of 2024 (1587)
Non-profit (601)
Northern California (492)
Obesity (109)
Opinion (111)
Patents (63)
People (28629)
Pharmaceutical (67)
Phase I (7953)
Phase II (12928)
Phase III (11606)
Pipeline (197)
Policy (46)
Postmarket research (1400)
Preclinical (3184)
Radiopharmaceuticals (116)
Rare diseases (105)
Real estate (2634)
Regulatory (9891)
Research institute (567)
Resumes & cover letters (55)
Southern California (490)
Startups (1629)
United States (4867)
Vaccines (114)
Weight loss (81)
Date
Last 7 days (223)
Last 30 days (773)
Last 365 days (12574)
2024 (12526)
2023 (14350)
2022 (19658)
2021 (20179)
2020 (19128)
2019 (14943)
2018 (11761)
2017 (13945)
2016 (13187)
2015 (15512)
2014 (12455)
2013 (10614)
2012 (11425)
2011 (11960)
2010 (10904)
Location
Africa (313)
Arizona (43)
Asia (19888)
Australia (2586)
California (1158)
Canada (670)
China (137)
Colorado (47)
Connecticut (47)
Europe (38964)
Florida (180)
Illinois (134)
Indiana (95)
Japan (51)
Kansas (51)
Maryland (172)
Massachusetts (999)
Minnesota (65)
New Jersey (494)
New York (324)
North Carolina (292)
Northern California (492)
Pennsylvania (318)
South America (499)
Southern California (490)
Texas (158)
Virginia (46)
Washington State (78)
263,103 Results for "neurotech pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurotech is Changing the Way We Treat Disease and Understand the Brain; Are Our Medical and Legal Institutions Ready?
The Dana Foundation Launches Neurotech Justice Accelerator at Mass General Brigham (NJAM) to Unite Science and Society and Mitigate Medical, Legal, and Ethical Risks
October 4, 2024
·
1 min read
Pharm Country
Neurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for NT-501 (revakinagene taroretcel) as a Treatment for Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals, Inc. announces that the U.S. Food and Drug Administration (FDA), has determined that the Biologic License Application (BLA) for NT-501, an investigational encapsulated cell therapy for the treatment of MacTel, is sufficiently complete to permit a substantive review.
June 20, 2024
·
3 min read
Press Releases
Neurotech Provides Update on BLA for NT-501 as a Treatment for Macular Telangiectasia Type 2 (MacTel)
November 8, 2024
·
2 min read
Press Releases
Neurotech Innovator UNEEG Medical Receives FDA Breakthrough Device Designation Within Monitoring and Diagnostic of Epilepsy
November 26, 2024
·
3 min read
Business
Alex Gorsky Joins Neurotech’s Board as Lead Director
Neurotech Pharmaceuticals, Inc., a private clinical stage biotech company, announced today that Alex Gorsky has been elected to Neurotech’s board as Lead Director.
September 13, 2023
·
3 min read
Biotech Beach
Convergent Research Announces Major New Funding Commitment to Forest Neurotech
Convergent Research today announced a new $14 million funding commitment from former Google CEO Eric Schmidt to Forest Neurotech, an initiative designed to create next-generation brain-computer-interfaces (BCIs) for individuals with neurological injuries or diseases.
March 11, 2024
·
2 min read
Lone Star Bio
Motif Neurotech Raises $18.75 Million in Series A Financing to Advance Implantable Device for Treatment-Resistant Depression
Motif Neurotech announced today an oversubscribed Series A financing of $18.75 million led by Arboretum Ventures.
January 24, 2024
·
3 min read
Business
Motif Neurotech Strengthens Leadership Team with Appointment of Steven Goetz as Chief Technology Officer
Motif Neurotech , a clinical-stage company developing minimally invasive bioelectronics for mental health, announces the appointment of Steven Goetz as Chief Technology Officer.
July 24, 2023
·
4 min read
Lone Star Bio
Motif Neurotech Conducts First-in-human Brain Stimulation With Millimeter-sized Implantable Device for Treatment-resistant Depression
Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health, announced today new research published to the preprint server medrxiv that demonstrates a millimeter-sized brain stimulator in a human subject.
September 18, 2023
·
5 min read
Biotech Beach
Neurotech Solutions Debuts MOXOedu Attention Assessment at ASU+GSV Summit
Neurotech Solutions continues to revolutionize attentional analytics with MOXOedu, a cloud-based tool that has been calibrated for assessing and profiling human attention
April 18, 2023
·
3 min read
1 of 26,311
Next
